Today: 20 May 2026
Palantir Stock Skyrockets 150% – Inside the AI Defense Giant’s Epic 2025 Rally

Palantir (PLTR) adds two AI deals today—Stagwell marketing platform and Spain’s Valoriza—after blowout Q3: stock, guidance and what to watch (Nov. 6, 2025)

Key takeaways

  • New today: Palantir announced two partnerships—one with Stagwell to build an AI-driven marketing platform and another with Valoriza to modernize urban environmental services in Spain. 
  • Context: Earlier this week, Palantir posted Q3 revenue of $1.181B (+63% Y/Y) and adjusted EPS of $0.21, and raised FY25 revenue guidance to $4.396–$4.400B
  • Pipeline detail: Management disclosed 204 Q3 deals ≥ $1M (including 91 ≥ $5M and 53 ≥ $10M). 
  • Stock check: See the live price and intraday move below.

What’s new on November 6

1) Stagwell partnership: AI platform for marketers

Palantir and Stagwell unveiled a joint product effort that pairs Palantir Foundry with Stagwell’s Code and Theoryorchestration layer and The Marketing Cloud data to give large brands a centralized, privacy-aware hub for campaign planning, audience alignment, and AI agents that automate complex marketing workflows. Early MVP adoption is underway via Stagwell’s media agency Assembly, with a broader opt‑in rollout planned. Stagwell CEO Mark Penn said the opportunity could scale to “hundreds of millions of dollars” over time, while Palantir CEO Alex Karp said the collaboration should make marketing “more dynamic.” PR Newswire

Why it matters: It’s another proof point of Palantir’s push beyond defense into commercial AI at scale, a segment that led growth in Q3. 

2) Valoriza partnership: smarter cities & environmental services

Separately, Palantir said Valoriza—a major Spanish environmental-services provider—will use AIP and Foundry to unify near‑real‑time data from IoT‑enabled waste containers, vehicle fleets, city infrastructure, and field workers. The goal: optimize routesreduce emissions, and improve service quality for municipalities across Spain. Financial terms weren’t disclosed. 

Why it matters: It extends Palantir’s European footprint and showcases industrial and municipal use cases for its AI stack—an area investors are watching as the company scales outside U.S. government programs. 


The backdrop: a big Q3 sets the stage

  • Revenue: $1.181B (+63% Y/Y, +18% Q/Q).
  • Adjusted EPS: $0.21; GAAP EPS: $0.18.
  • Cash/short‑term treasuries: $6.4B; no debt.
  • Deal activity: 204 deals ≥ $1M; 91 ≥ $5M; 53 ≥ $10M.
  • U.S. commercial revenue: +121% Y/Y to $397MU.S. government: +52% Y/Y to $486M.
    All figures per the company’s earnings release and investor materials. 

Guidance: For Q4 2025, Palantir guided to $1.327–$1.331B in revenue and $695–$699M in adjusted operating income. For FY 2025, management raised revenue guidance to $4.396–$4.400B and now expects $1.9–$2.1B in adjusted FCF. 

Street & market reaction this week: Coverage emphasized that robust AI demand underpins the outlook; valuation remains a debate even after the raise. 


What it means for PLTR

Short term: Today’s Stagwell and Valoriza announcements add near‑term commercial catalysts—one in adtech/marketing and another in smart‑city operations—that could translate to incremental deal flow as MVPs turn into network‑wide deployments. 

Medium term: The two wins reinforce the Q3 trend: commercial is now the growth engine. If Palantir continues to land cross‑industry platforms (manufacturing, marketing, municipal services), the company’s mix should grow more diversified and less episodic than traditional government awards. 

Risks to monitor: Execution and conversion risk from pilots to scaled contracts; macro‑driven budget delays; and the ever‑present valuation debate after a major run‑up this year. 


Today’s PLTR price at a glance

Use the interactive chart above for the latest move and intraday range. (Data time‑stamped in the widget.)


The bottom line

On Nov. 6, 2025, Palantir pressed its AI advantage beyond defense with two new commercial partnerships—a marketer‑facing platform with Stagwell and a smart‑city deployment with Valoriza—while investors continue to digest this week’s record Q3, strong Q4/FY25 guidance, and what all of it implies for PLTR’s premium multiple. 


Sources & further reading

  • Palantir–Stagwell partnership announcement (press release). 
  • Palantir–Valoriza partnership announcement (press release). 
  • Palantir Q3 2025 earnings release (SEC Exhibit 99.1). 
  • Q3 2025 investor presentation (revenue, deals, guidance visuals). 
  • Coverage of Q4 outlook and valuation backdrop. 

This article is for informational purposes only and is not investment advice.

Stock Market Today

  • Stock Market Today May 20: Nasdaq Rises 1.5% on Renewed Risk Appetite
    May 20, 2026, 5:43 PM EDT. The S&P 500 gained 1.08% to 7,432.97, Nasdaq rose 1.54% to 26,270.36, and Dow advanced 1.31% to 50,009.34 amid falling oil prices and easing Treasury yields. AI hardware stocks like AMD and Super Micro Computer led gains, with Nvidia up 1.3% before its earnings report. Software names Salesforce and CrowdStrike also recovered. Hasbro declined nearly 9% despite beating earnings forecasts due to cautious guidance. Investor optimism reflects hopes for an end to the U.S.-Iran conflict, lowering West Texas Intermediate crude by 5% to $99 a barrel. Nvidia's earnings beat was met with muted reaction as investors awaited stronger sales forecasts. The Motley Fool highlighted other top stock picks, noting Nvidia and Netflix's historic outperformance over the S&P 500.

Latest articles

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
FuelCell Energy surges as AI-fueled rally hits again, analysts wary

FuelCell Energy surges as AI-fueled rally hits again, analysts wary

20 May 2026
FuelCell Energy shares surged 16.5% to $20.22 Wednesday, rebounding after a two-day selloff. The move tracked a 1.5% gain in the Nasdaq Composite and renewed interest in companies supplying power to AI data centers. FuelCell reported a $26.1 million quarterly loss and a declining backlog, despite higher revenue and new data-center proposals. Peers traded mixed, with Bloom Energy up and Plug Power down.
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts
Previous Story

Tesla (TSLA) Today: Shareholders Vote on Musk’s Record Pay, Cybertruck Lineup Shifts—What It Means for the Stock (Nov. 6, 2025)

IREN’s 500% Rally: How a Bitcoin Miner Became an AI Cloud Juggernaut
Next Story

IREN (Iris Energy) Earnings Today — Nov 6, 2025: Revenue Soars 355% to $240.3M, Net Income Hits $384.6M as Microsoft AI Megadeal Anchors $3.4B ARR Target

Go toTop